IDYA - IDEAYA Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

IDEAYA Biosciences, Inc.

7000 Shoreline Court
Suite 350
South San Francisco, CA 94080
United States

Full Time Employees56

Key Executives

NameTitlePayExercisedYear Born
Mr. Yujiro S. HataCo-Founder, CEO, Pres & Director575kN/A1974
Mr. Paul A. StoneCFO, Gen. Counsel & Principal Accounting Officer351.55kN/A1964
Dr. Julie HambletonSr. VP, Chief Medical Officer & Head of Devel.285.43kN/A1958
Mr. Jeffrey HagerSr. VP, CTO, Head of Target Discovery & External InnovationN/AN/A1964
Mr. Michael P. DillonSr. VP, Chief Scientific Officer & Head of ResearchN/AN/A1967
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


IDEAYA Biosciences, Inc., an oncology-focused precision medicine company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate in clinical development is IDE196, a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting MAT2A in tumor cells having MTAP gene deletions; Pol-theta in tumors with genetic mutations in homologous recombination deficiency, including BRCA mutations; PARG in tumors with genetic mutations in base excision repair; and WRN in high microsatellite instability tumors. The company was founded in 2015 and is headquartered in South San Francisco, California.

Corporate Governance

IDEAYA Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.